Skip to content

Examining Validity and Reliability of the Shared Decision Making Process Survey in Adults With Depression

Online Trial Examining Validity and Reliability of the Shared Decision Making Process Survey in Adults With Depression

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04343534
Enrollment
494
Registered
2020-04-13
Start date
2020-04-29
Completion date
2020-12-30
Last updated
2024-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Keywords

shared decision making

Brief summary

The purpose of this study is to test two differently worded versions of the Shared Decision Making Process scale in a sample of adults who have recently made a decision about treatment of depression. The main goals are to gather evidence of reliability, to test whether the generic version has similar psychometric performance to the original, and to extend generalizability of the findings to younger adults.

Detailed description

The purpose of this study is to test two differently worded versions of the Shared Decision Making Process scale in a sample of adults who have recently made a decision about treatment of depression. The main goals are to gather evidence of psychometric performance of the scale, compare performance of different wording for items, and to extend generalizability of the findings to younger adults. Subjects are randomly assigned to one of the two versions of the Shared Decision Making Process scale and complete a set of measures regarding their experiences with decision making for depression, demographics, and health status. A subset of respondents will complete the Shared Decision Making Process scale and selected other items again 1 week later to examine short term test-retest reliability. Staff will work with a national sampling firm to recruit subjects and obtain 500 responses to the baseline survey (n=250 for each version) and a subset will complete a retest survey (n=200; 50 from each age and survey type group). Eligible subjects are adults aged 18-75 who talked with a health care provider about treatment for depression in the preceding 12 months. The sample is not a national probability sample; however, the recruitment efforts will ensure about 50% of respondents aged 18-39 and 50% aged 40-75, and to ensure at least 25% of the sample is racial/ethnic minorities (Black or African American, Asian, Hispanic or Latino). The investigators will examine validity and reliability of the different versions. The sample size was determined to ensure sufficient power to detect differences in key subgroups, including age (younger adults vs. older adults) and version (A vs. B). To detect a difference of about 0.33 standard deviations at 0.05 significance with 80% power would require 125 per group.

Interventions

None listed

Sponsors

University of Massachusetts, Boston
CollaboratorOTHER
Massachusetts General Hospital
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Must have spoken to a healthcare provider about treatment for depression in the past 12 months * Must have started or stopped medication for depression between January 2018 and their surveyed date.

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Shared Decision Making Process ScoreBaseline surveyThe Shared Decision Making Process is a short patient-reported survey that measures the amount of shared decision making that occurs in an interaction. Scores for both versions of the scale range from 0-4 where higher values indicate a better shared decision making process occurred.

Secondary

MeasureTime frameDescription
Decision Regret ScaleBaseline survey5-item decision regret scale ranges from 0-100 with higher scores indicating greater decisional regret.
Single-Item Measure of Decision RegretBaseline surveySingle item asking If you knew then what you know now, do you think you would make the same decision about depression? Responses are definitely yes, probably yes, probably no and definitely no.
Treatment PreferenceBaseline surveySingle item asking What did you want to do to manage your depression with response options (1) Anti-depressant medicine alone, (2) Counseling or therapy alone, (3) Both medicine and counseling, and (4) Do something else.
Decisional Conflict Tool (SURE)Baseline surveyMeasures decisional conflict, consists of 4 yes/no items. Scores range 0-4 where 0 indicates high decisional conflict, 4 indicates no decisional conflict, and scores less than or equal to 3 indicate decisional conflict. The measure is top-scored and we report the percentage of participants who scored a 4 (no decisional conflict).
Shared Decision Making Process Measure Retest1 week after baseline surveyThe Shared Decision Making Process is a short patient-reported survey that measures the amount of shared decision making that occurs in an interaction. Scores range from 0-4 where higher values indicate a better shared decision making process occurred.
Depression KnowledgeBaseline surveyMultiple choice knowledge items for each topic will be combined to a total knowledge score (0-100) with higher scores indicating higher knowledge
AdherenceBaseline survey3 item measure of adherence to medication for sample participants who indicate that they are taking medicine. A total score is calculated with scores ranging form 0-100; higher values indicated greater medication adherence.
Adapted Controlled Preference ScaleBaseline surveySingle item asking the participant who made the ultimate decision. The categorical response options are 1) the patient made the decision, 2)the provider made the decision, or 3) both patient and provider made the decision together.

Countries

United States

Participant flow

Recruitment details

April 2020 - May 2020 using a national, non-probability panel obtained from Marketing Systems Group (MSG). MSG recruited participants by sending out invitation emails to potential responders.

Pre-assignment details

Eligible respondents were adults in the US who had talked with a healthcare provider about starting or stopping medication for depression in the past 12 months. The sample was selected to have approximately equal age distribution above and below 40 years old (e.g. 18-39 and 40-75). Respondents were re-contacted approximately one-week post survey for a re-test survey.

Participants by arm

ArmCount
Original Shared Decision Making Process Scale
Patients receive the original version of the Shared Decision Making Process scale.
230
Revised Shared Decision Making Process Scale
This group completes a new version of the scale with different wording for several items.
264
Total494

Baseline characteristics

CharacteristicOriginal Shared Decision Making Process ScaleTotalRevised Shared Decision Making Process Scale
Age, Continuous42 years
STANDARD_DEVIATION 14
43 years
STANDARD_DEVIATION 14
44 years
STANDARD_DEVIATION 14
Ethnicity (NIH/OMB)
Hispanic or Latino
12 Participants35 Participants23 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
218 Participants459 Participants241 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
2 Participants3 Participants1 Participants
Race (NIH/OMB)
Asian
8 Participants14 Participants6 Participants
Race (NIH/OMB)
Black or African American
12 Participants26 Participants14 Participants
Race (NIH/OMB)
More than one race
5 Participants13 Participants8 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
10 Participants21 Participants11 Participants
Race (NIH/OMB)
White
193 Participants417 Participants224 Participants
Region of Enrollment
United States
230 Participants494 Participants264 Participants
Sex/Gender, Customized
Female
158 Participants355 Participants197 Participants
Sex/Gender, Customized
Male
72 Participants138 Participants66 Participants
Sex/Gender, Customized
Non-Binary
0 Participants1 Participants1 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 2300 / 264
other
Total, other adverse events
0 / 2300 / 264
serious
Total, serious adverse events
0 / 2300 / 264

Outcome results

Primary

Shared Decision Making Process Score

The Shared Decision Making Process is a short patient-reported survey that measures the amount of shared decision making that occurs in an interaction. Scores for both versions of the scale range from 0-4 where higher values indicate a better shared decision making process occurred.

Time frame: Baseline survey

Population: participants who answered the shared decision making process items and provided sufficient information to calculate a SDM Process score.

ArmMeasureValue (MEAN)Dispersion
Original Shared Decision Making Process ScaleShared Decision Making Process Score2.35 score on a scaleStandard Deviation 1.11
Revised Shared Decision Making Process ScaleShared Decision Making Process Score2.51 score on a scaleStandard Deviation 1.05
Comparison: SDM Process score distributions were compared to determine of the scores spanned the range of possible values, were normally distributed, had low rates of missing data, and whether there was indications of floor or ceiling effects.~we conducted independent t-tests to determine if there were differences in SDM Process scores between the two versions.p-value: 0.09295% CI: [-0.02, 0.33]t-test, 2 sided
Secondary

Adapted Controlled Preference Scale

Single item asking the participant who made the ultimate decision. The categorical response options are 1) the patient made the decision, 2)the provider made the decision, or 3) both patient and provider made the decision together.

Time frame: Baseline survey

Population: participants who answered the controlled preference scale question.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Original Shared Decision Making Process ScaleAdapted Controlled Preference ScaleMainly my decision107 Participants
Original Shared Decision Making Process ScaleAdapted Controlled Preference ScaleMainly the healthcare provider's decision32 Participants
Original Shared Decision Making Process ScaleAdapted Controlled Preference ScaleWe made the decision together91 Participants
Revised Shared Decision Making Process ScaleAdapted Controlled Preference ScaleMainly my decision125 Participants
Revised Shared Decision Making Process ScaleAdapted Controlled Preference ScaleWe made the decision together112 Participants
Revised Shared Decision Making Process ScaleAdapted Controlled Preference ScaleMainly the healthcare provider's decision27 Participants
Secondary

Adherence

3 item measure of adherence to medication for sample participants who indicate that they are taking medicine. A total score is calculated with scores ranging form 0-100; higher values indicated greater medication adherence.

Time frame: Baseline survey

Population: participants who completed all 3 measures of adherence to calculate an adherence score. 373/494 provided sufficient information to calculate an adherence score.

ArmMeasureValue (MEAN)Dispersion
Original Shared Decision Making Process ScaleAdherence83.6 score on a scaleStandard Deviation 18.47
Revised Shared Decision Making Process ScaleAdherence84.79 score on a scaleStandard Deviation 18.25
Secondary

Decisional Conflict Tool (SURE)

Measures decisional conflict, consists of 4 yes/no items. Scores range 0-4 where 0 indicates high decisional conflict, 4 indicates no decisional conflict, and scores less than or equal to 3 indicate decisional conflict. The measure is top-scored and we report the percentage of participants who scored a 4 (no decisional conflict).

Time frame: Baseline survey

Population: participants who completed all 4 items of the short decisional conflict scale. Only 485/494 participants provided enough information to calculate a SURE score.

ArmMeasureValue (NUMBER)
Original Shared Decision Making Process ScaleDecisional Conflict Tool (SURE)63 percentage of patients
Revised Shared Decision Making Process ScaleDecisional Conflict Tool (SURE)72 percentage of patients
Secondary

Decision Regret Scale

5-item decision regret scale ranges from 0-100 with higher scores indicating greater decisional regret.

Time frame: Baseline survey

Population: Participants who answered all 5 decision regret questions. All 494 participants provided enough information to calculate decision regret score.

ArmMeasureValue (MEAN)Dispersion
Original Shared Decision Making Process ScaleDecision Regret Scale23 score on a scaleStandard Deviation 18
Revised Shared Decision Making Process ScaleDecision Regret Scale21 score on a scaleStandard Deviation 20
Secondary

Depression Knowledge

Multiple choice knowledge items for each topic will be combined to a total knowledge score (0-100) with higher scores indicating higher knowledge

Time frame: Baseline survey

Population: participants who completed at least 60% of the knowledge questions for their respective cancer screening group. All 494 participants provided sufficient information to calculate a knowledge score.

ArmMeasureValue (MEAN)Dispersion
Original Shared Decision Making Process ScaleDepression Knowledge55.22 percentage of correct answersStandard Deviation 22.96
Revised Shared Decision Making Process ScaleDepression Knowledge55.98 percentage of correct answersStandard Deviation 21.87
Secondary

Shared Decision Making Process Measure Retest

The Shared Decision Making Process is a short patient-reported survey that measures the amount of shared decision making that occurs in an interaction. Scores range from 0-4 where higher values indicate a better shared decision making process occurred.

Time frame: 1 week after baseline survey

Population: A subset of participants who completed the baseline survey (n=200) were re-contacted approximately 1 week post-survey for a retest. Participants who completed the retest survey and provided enough information to calculate the shared decision making process score were part of this analysis. 163/200 participants provided sufficient information to calculate a retest SDM Process score.

ArmMeasureValue (MEAN)Dispersion
Original Shared Decision Making Process ScaleShared Decision Making Process Measure Retest2.27 score on a scaleStandard Deviation 1.05
Revised Shared Decision Making Process ScaleShared Decision Making Process Measure Retest2.58 score on a scaleStandard Deviation 0.97
Secondary

Single-Item Measure of Decision Regret

Single item asking If you knew then what you know now, do you think you would make the same decision about depression? Responses are definitely yes, probably yes, probably no and definitely no.

Time frame: Baseline survey

Population: participants who answered the single-item regret question.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Original Shared Decision Making Process ScaleSingle-Item Measure of Decision RegretProbably yes95 Participants
Original Shared Decision Making Process ScaleSingle-Item Measure of Decision RegretDefinitely no1 Participants
Original Shared Decision Making Process ScaleSingle-Item Measure of Decision RegretProbably no15 Participants
Original Shared Decision Making Process ScaleSingle-Item Measure of Decision RegretDefinitely yes119 Participants
Revised Shared Decision Making Process ScaleSingle-Item Measure of Decision RegretProbably no24 Participants
Revised Shared Decision Making Process ScaleSingle-Item Measure of Decision RegretDefinitely yes134 Participants
Revised Shared Decision Making Process ScaleSingle-Item Measure of Decision RegretProbably yes102 Participants
Revised Shared Decision Making Process ScaleSingle-Item Measure of Decision RegretDefinitely no4 Participants
Secondary

Treatment Preference

Single item asking What did you want to do to manage your depression with response options (1) Anti-depressant medicine alone, (2) Counseling or therapy alone, (3) Both medicine and counseling, and (4) Do something else.

Time frame: Baseline survey

Population: participants who answered the treatment preference question. 493/494 provided information for this question

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Original Shared Decision Making Process ScaleTreatment PreferenceAnti-depressant medicine alone71 Participants
Original Shared Decision Making Process ScaleTreatment PreferenceCounseling or therapy alone28 Participants
Original Shared Decision Making Process ScaleTreatment PreferenceBoth medicine and counseling125 Participants
Original Shared Decision Making Process ScaleTreatment PreferenceDo something else6 Participants
Revised Shared Decision Making Process ScaleTreatment PreferenceDo something else6 Participants
Revised Shared Decision Making Process ScaleTreatment PreferenceAnti-depressant medicine alone91 Participants
Revised Shared Decision Making Process ScaleTreatment PreferenceBoth medicine and counseling138 Participants
Revised Shared Decision Making Process ScaleTreatment PreferenceCounseling or therapy alone28 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026